Coya Therapeutics, Inc. (COYA)
Nasdaq: COYA · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2021
Who runs Coya Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Swaminathan Arun
Chief Executive Officer. First filing Aug 2024, latest Jan 26, 2026, 2 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
12 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Swaminathan Arun | Chief Executive Officer | Aug 2024 | Jan 26, 2026 | none |
| Berman Howard | Executive Chairman | Dec 2022 | Jan 26, 2026 | none |
| Snyder David S | Chief Financial Officer | Dec 2022 | Jan 26, 2026 | none |
| Grossman Fred | Chief Medical Officer | Jul 2023 | Jan 26, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Pavao Mark H | director | Apr 2026 | Apr 9, 2026 | none |
| Goldstein Dov A Md | director | Dec 2022 | Jan 6, 2026 | none |
| Lee Ann | director | Dec 2022 | Jan 6, 2026 | none |
| Ross Wilbur L Jr | director | Dec 2023 | Jan 6, 2026 | none |
| Villalobos Anabella | director | Dec 2022 | Jan 6, 2026 | none |
| Weinand Dieter | director | Aug 2023 | Jan 6, 2026 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.